Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)WithdrawnNCT00054392What this trial is testingCombination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01806675What this trial is testing18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT00309998What this trial is testingVinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer University of Rochester 50
Testing effectiveness (Phase 2)UnknownNCT00513266What this trial is testingCombination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryWho this might be right forColorectal CancerMetastatic Cancer Centre Hospitalier Universitaire Vaudois 35
Large-scale testing (Phase 3)Ended earlyNCT04588246What this trial is testingComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more NRG Oncology 19
Early research (Phase 1)Looking for participantsNCT04119024What this trial is testingGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more Anusha Kalbasi 18
Testing effectiveness (Phase 2)Study completedNCT00217698What this trial is testingGefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Swiss Cancer Institute 63
Testing effectiveness (Phase 2)Study completedNCT00033384What this trial is testingCI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+1 more University of Alabama at Birmingham
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Testing effectiveness (Phase 2)Study completedNCT00103207What this trial is testingCetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung CancerWho this might be right forLung Cancer Eastern Cooperative Oncology Group 72
Large-scale testing (Phase 3)Ended earlyNCT02231164What this trial is testingLUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational ResearchWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 12
Early research (Phase 1)Study completedNCT00734890What this trial is testingVandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+2 more National Institutes of Health Clinical Center (CC) 18
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Ended earlyNCT01208064What this trial is testingPazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line ChemotherapyWho this might be right forLung Cancer European Organisation for Research and Treatment of Cancer - EORTC 102
Testing effectiveness (Phase 2)Study completedNCT01344824What this trial is testingCarboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never SmokersWho this might be right forLung Cancer UNC Lineberger Comprehensive Cancer Center 38
Early research (Phase 1)Ended earlyNCT02650635What this trial is testingTLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsWho this might be right forColorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more Mayo Clinic 4
Testing effectiveness (Phase 2)Study completedNCT02303977What this trial is testingPhase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based ChemotherapyWho this might be right forPatients With Stage IV or Recurrent Adenocarcinoma of the Lung Abramson Cancer Center at Penn Medicine 37
Early research (Phase 1)Study completedNCT00016237What this trial is testingInterleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous TreatmentWho this might be right forBladder CancerKidney CancerLung Cancer EMD Serono